Trials / Completed
CompletedNCT03181191
The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Delineation of the anatomical location, cellular origin and molecular basis of gut-derived glucagon secretion
Detailed description
Aim: to delineate the anatomical origin, the molecular structure and precursors, the regulation and the (patho-) physiological implications of gut-derived glucagon. Eight totally pancreatectomised patients, eight type 2 diabetes patients and eight healthy controls (age 18-80, BMI \<30) with normal kidney and liver parameters and hgb\> 6.5 - will be included. The participants will each undergo one screening day and one study day including a gastroduodenoscopy. Multiple biopsies will be taken at several predefined locations in the upper gastrointestinal tract. These biopsies will be analysed with different techniques including immunohistochemical staining, quantitative polymerase chain reaction (qPCR-) analyses and more to search for glucagon. After the last biopsy has been collected, 50 g of glucose dissolved in 100 ml water is infused through the enteroscope into the most proximal part of the small intestine. Hereafter blood samples for glucagon and gut hormone analyses will be collected 15, 30 and 45 min after the glucose infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oral glucose tolerance test | Oral glucose tolerance test and biopsies |
Timeline
- Start date
- 2017-04-27
- Primary completion
- 2017-12-03
- Completion
- 2017-12-03
- First posted
- 2017-06-08
- Last updated
- 2019-09-04
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03181191. Inclusion in this directory is not an endorsement.